Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia

Abate Dargie Wubetu,1 Kokebie Kefelegn Asefa,2 Birhan Gebresillassie Gebregiorgis2 1Debre Berhan University, College of Health Science, Department of Psychiatry, Debre Berhan, Ethiopia; 2Debre Berhan University, College of Health Science, Department of Nursing, Debre Berhan, EthiopiaCorrespondence:...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wubetu AD, Asefa KK, Gebregiorgis BG
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	hiv haart cognition neurocognitive deficit ethiopia Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/35715cc21dca4bf5beec05db9cfbeb9e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:35715cc21dca4bf5beec05db9cfbeb9e
record_format	dspace
spelling	oai:doaj.org-article:35715cc21dca4bf5beec05db9cfbeb9e2021-12-02T14:26:22ZPrevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia1179-1373https://doaj.org/article/35715cc21dca4bf5beec05db9cfbeb9e2021-04-01T00:00:00Zhttps://www.dovepress.com/prevalence-of-neurocognitive-impairment-and-associated-factors-among-p-peer-reviewed-article-HIVhttps://doaj.org/toc/1179-1373Abate Dargie Wubetu,1 Kokebie Kefelegn Asefa,2 Birhan Gebresillassie Gebregiorgis2 1Debre Berhan University, College of Health Science, Department of Psychiatry, Debre Berhan, Ethiopia; 2Debre Berhan University, College of Health Science, Department of Nursing, Debre Berhan, EthiopiaCorrespondence: Abate Dargie WubetuDebre Berhan University, College of Health Science, Department of Psychiatry Tel +251 910916569Email abatedargie2001@gmail.comBackground: The burden of HIV is mainly found in Sub Saharan Africa. The HIV-associated neurocognitive impairment is found to be higher and it can exist at all stages of HIV. The HIV-associated neurocognitive impairment has a significant impact on a patient’s daily living and highly active antiretroviral treatment (HAART) adherence. Therefore, this study aimed to determine the prevalence and associated factors of HIV-associated neurocognitive impairment among adult people on HIV treatment.Methods: A total of 423 people living with HIV/AIDS were planned to include in the study. A systematic random sampling technique was used to get the study participants. Binary logistic regression analysis was used to identify associated factors of HIV-associated neurocognitive impairment. Factors with a p-value of ≤ 0.2 on bivariate analyses were recruited for multivariate logistic regression analyses, and 95% CI at p-value < 0.05 was considered as statistically significant. Variance inflation factors for continuous variables and Spearman rank correlation for categorical variables were performed. There was no multicollinearity between suspected predictor variables. Model fitness was checked using Hosmer and Lemeshow Test, and its p-value was 0.45.Result: A total of 422 individuals on HAART were included which gave a response rate of 99.8%. The prevalence of HIV-associated neurocognitive impairment was 41% (95% CI=36.3, 45.6). Older individuals, low monthly income, having comorbid depression and anxiety, have no communication about safe sexual intercourse, higher duration of HIV illness, and having poor social support were statistically significant associated factors of HIV neurocognitive impairment.Conclusion: Two among five HIV patients on HAART treatment experienced HIV-associated neurocognitive impairment. It will be better if health professionals working at the HIV/TB clinic screen and consult HIV patients for psychiatric evaluation and treatment. Due attention should be given to HIV patients with associated factors.Keywords: HIV, HAART, cognition, neurocognitive deficit, EthiopiaWubetu ADAsefa KKGebregiorgis BGDove Medical Pressarticlehivhaartcognitionneurocognitive deficitethiopiaImmunologic diseases. AllergyRC581-607ENHIV/AIDS: Research and Palliative Care, Vol Volume 13, Pp 425-433 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	hiv haart cognition neurocognitive deficit ethiopia Immunologic diseases. Allergy RC581-607
spellingShingle	hiv haart cognition neurocognitive deficit ethiopia Immunologic diseases. Allergy RC581-607 Wubetu AD Asefa KK Gebregiorgis BG Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia
description	Abate Dargie Wubetu,1 Kokebie Kefelegn Asefa,2 Birhan Gebresillassie Gebregiorgis2 1Debre Berhan University, College of Health Science, Department of Psychiatry, Debre Berhan, Ethiopia; 2Debre Berhan University, College of Health Science, Department of Nursing, Debre Berhan, EthiopiaCorrespondence: Abate Dargie WubetuDebre Berhan University, College of Health Science, Department of Psychiatry Tel +251 910916569Email abatedargie2001@gmail.comBackground: The burden of HIV is mainly found in Sub Saharan Africa. The HIV-associated neurocognitive impairment is found to be higher and it can exist at all stages of HIV. The HIV-associated neurocognitive impairment has a significant impact on a patient’s daily living and highly active antiretroviral treatment (HAART) adherence. Therefore, this study aimed to determine the prevalence and associated factors of HIV-associated neurocognitive impairment among adult people on HIV treatment.Methods: A total of 423 people living with HIV/AIDS were planned to include in the study. A systematic random sampling technique was used to get the study participants. Binary logistic regression analysis was used to identify associated factors of HIV-associated neurocognitive impairment. Factors with a p-value of ≤ 0.2 on bivariate analyses were recruited for multivariate logistic regression analyses, and 95% CI at p-value < 0.05 was considered as statistically significant. Variance inflation factors for continuous variables and Spearman rank correlation for categorical variables were performed. There was no multicollinearity between suspected predictor variables. Model fitness was checked using Hosmer and Lemeshow Test, and its p-value was 0.45.Result: A total of 422 individuals on HAART were included which gave a response rate of 99.8%. The prevalence of HIV-associated neurocognitive impairment was 41% (95% CI=36.3, 45.6). Older individuals, low monthly income, having comorbid depression and anxiety, have no communication about safe sexual intercourse, higher duration of HIV illness, and having poor social support were statistically significant associated factors of HIV neurocognitive impairment.Conclusion: Two among five HIV patients on HAART treatment experienced HIV-associated neurocognitive impairment. It will be better if health professionals working at the HIV/TB clinic screen and consult HIV patients for psychiatric evaluation and treatment. Due attention should be given to HIV patients with associated factors.Keywords: HIV, HAART, cognition, neurocognitive deficit, Ethiopia
format	article
author	Wubetu AD Asefa KK Gebregiorgis BG
author_facet	Wubetu AD Asefa KK Gebregiorgis BG
author_sort	Wubetu AD
title	Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia
title_short	Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia
title_full	Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia
title_fullStr	Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia
title_full_unstemmed	Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia
title_sort	prevalence of neurocognitive impairment and associated factors among people living with hiv on highly active antiretroviral treatment, ethiopia
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/35715cc21dca4bf5beec05db9cfbeb9e
work_keys_str_mv	AT wubetuad prevalenceofneurocognitiveimpairmentandassociatedfactorsamongpeoplelivingwithhivonhighlyactiveantiretroviraltreatmentethiopia AT asefakk prevalenceofneurocognitiveimpairmentandassociatedfactorsamongpeoplelivingwithhivonhighlyactiveantiretroviraltreatmentethiopia AT gebregiorgisbg prevalenceofneurocognitiveimpairmentandassociatedfactorsamongpeoplelivingwithhivonhighlyactiveantiretroviraltreatmentethiopia
_version_	1718391361378451456

Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia

Ejemplares similares